Search

In this article the author discusses about his personal experiences with a potential cervical cancer diagnosis, and his anxiety and anticipation surrounding the biopsy results.

China has made free human papillomavirus (HPV) vaccinations available to approximately 40 percent of girls aged 13 to 14 in the fight against cervical cancer. Since 2021, 11 provincial-level regions and multiple cities have offered free vaccination services for eligible girls. The National Health Commission reports that 280 million free HPV screenings have been conducted in China, aiding in early detection and treatment of cervical cancer. Additionally, efforts have been made to provide medical assistance to 275,000 cervical cancer patients in financial need. China aims to reduce the incidence rate of cervical cancer to 4 per 100,000 by the end of the century, as part of a global initiative to eliminate the disease. [Extracted from the article]

A recent study conducted in China explored the use of shear wave elastography (SWE) as an auxiliary examination method for the detection and evaluation of cervical cancer. The study found that SWE technology has potential application value in the diagnosis and clinical staging of cervical cancer. The mean and maximum values of elastic modulus obtained through SWE had higher diagnostic accuracy. However, further research with larger sample sizes is needed to validate these findings. [Extracted from the article]

A recent study conducted in Beijing, China, has developed two models aimed at improving the segmentation of cervical tumors. The first model is semi-automatic and achieved a high level of accuracy, while the second model is fully automated and outperformed existing methods. These models have the potential to enhance cervical cancer diagnosis and treatment, particularly in resource-limited settings. The study utilized a dataset of 8586 MRI slices and leveraged artificial intelligence techniques to achieve superior accuracy and robustness in the automated segmentation of cervical cancer images. [Extracted from the article]

A recent study conducted at Beth Israel Deaconess Medical Center in Boston, Massachusetts, explored the implementation and outcomes of a financial navigation program (FNP) in gynecologic oncology. The study found that approximately 50% of gynecologic oncology patients experience "Financial Toxicity" (FT), which refers to the financial burden imposed on patients due to disease and its treatment. The FNP, which included a financial navigator (FN) and FT screening, was found to be feasible and effective in addressing the needs of patients. However, further investigation is needed to understand screening barriers and evaluate the long-term impact of the program. [Extracted from the article]

A recent study conducted at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida explored the perspectives of patients and providers on therapeutic vaccines for cervical cancer. The study found that both patients and providers expressed enthusiasm for the potential of a therapeutic vaccine, as it could offer less invasive treatment options. However, barriers such as concerns about side effects, eligibility criteria, costs, transportation, and logistical obstacles were identified. Providers also highlighted structural barriers such as racism and limited availability of culturally sensitive educational aids, emphasizing the need for provider training on this topic. The findings of this study can contribute to the development of patient-centered tools that promote acceptance of therapeutic vaccines for cervical cancer. [Extracted from the article]

A patent has been issued for an automatic cervical cancer diagnosis system developed by Aidot Inc. The system utilizes machine learning to classify cervical cancer learning data and automatically diagnose cervical cancer based on accurate criteria. It also provides a user interface screen for reading specialists to input evaluation information, which can be used for real-time retraining of the machine learning model. The system aims to improve the accuracy and convenience of cervical cancer diagnosis. [Extracted from the article]

A recent study conducted at the Jigme Dorji Wangchuck National Referral Hospital in Bhutan has reported on the management of cervical cancer in pregnancy in a low resource setting. The study presents a rare case of cervical cancer diagnosed at 28+5 weeks of gestation and successfully managed at 37+2 weeks in a 27-year-old woman. This is the first case report on cervical cancer in pregnancy from Bhutan and highlights the challenges of diagnosis and management in a low resource country. The study provides valuable insights into the complexities of managing cervical cancer during pregnancy in resource-limited settings. [Extracted from the article]

Researchers at Southern Medical University in Guangzhou, China have developed a new method for analyzing multi-center cervical cytology images. These images often have different styles due to variations in staining and imaging techniques, which can make automated diagnosis tools less effective. The researchers propose a dual-head network architecture that separates image features into content and style, and use contrastive self-supervised learning to improve generalization across different styles. Their method achieved the highest accuracy among all tested methods for each style, demonstrating its potential to enhance automated cytology image analysis in multi-center settings. [Extracted from the article]

A study conducted by researchers at Delhi Technological University in India has explored the use of Digital Twin (DT) technology in the diagnosis of cervical cancer. The researchers developed an automated cervical cancer detection framework using machine learning and image classification techniques. The framework achieved a high accuracy rate of 98.91% in classifying cervical cancer cases, particularly with support vector machines (SVM). The study suggests that integrating DT with the healthcare industry can enhance healthcare procedures and improve patient outcomes. [Extracted from the article]

A recent study conducted in Hunan, China has developed a new framework called the Integrated Attention-Transformer System (IATS) to improve the accuracy and efficiency of cervical cancer cell image analysis. The IATS combines the power of transformers and deep learning models to capture both global and local features within the images, resulting in a 2.5% accuracy improvement compared to the best-performing deep learning model. This advancement has the potential to revolutionize cervical cancer screening by reducing misdiagnosis rates and improving patient outcomes. Future work will focus on the computational efficiency and real-world integration of the framework. [Extracted from the article]

Research on cancer coaching is emerging, but studies have found that health coaching in general can significantly reduce hospitalizations in patients with chronic obstructive pulmonary disease, and also improve quality of life among cancer survivors. Burkus became a cancer coach because she wished she had access to one when she was undergoing treatment, and Panju only found out about cancer coaching by chance, through a friend. UTERINE CANCER According to UHN's Gynecologic Oncology divison, uterine cancer is the fourth most common type of cancer in women. But cancer coaches help patients in different ways: The process is goal-oriented and promotes health and wellness education while building confidence to help patients better cope with treatment. [Extracted from the article]

A recent study conducted by researchers from Shandong University of Traditional Chinese Medicine explores the role of extracellular vesicles and macrophages in the microenvironment of cervical cancer. The study highlights the potential of extracellular vesicles as new targets for treatment and emphasizes the close connection between macrophages and the development of cervical cancer. The research provides insights into the mechanism of action and application prospects of these factors in the diagnosis and treatment of cervical cancer. For more information, the full article can be accessed through the provided link. [Extracted from the article]

A recent report from researchers at Baylor College of Medicine highlights the importance of geospatial analysis in identifying priority communities for cervical cancer prevention in Texas. The study found that despite being preventable, cervical cancer remains one of the most frequently diagnosed cancers among women worldwide. The researchers used spatial scan analysis to identify seven significant hot spots of cervical cancer incidence in Texas, which were predominantly located in regions with higher proportions of Hispanic population and individuals with socioeconomic disadvantages. The findings suggest that targeted interventions, such as increased HPV vaccination and screening, are needed in these hot spot areas to address the disparities in cervical cancer incidence. [Extracted from the article]

A patent has been issued for a uterine cervical image acquisition apparatus developed by Aidot Inc. The invention aims to provide a convenient and user-friendly device for capturing uterine cervical images. It includes features such as a camera, user interface, handlebar unit, light source unit, battery, and operation buttons. The apparatus also has capabilities for storing and transmitting images, correcting image inclination, and interworking with an application program for automatic diagnosis of uterine cervical cancer. This technology is seen as a significant advancement in the field of women's health and oncology. [Extracted from the article]

A study conducted by researchers at Wenzhou Medical University in China has found that the complement regulatory protein CD46 may serve as a biomarker for the diagnosis and prognosis evaluation of cervical cancer. The study analyzed the levels of soluble CD46 (sCD46) in the plasma and the expression of membrane-bound CD46 (mCD46) in cervical cancer tissues. The results showed that CD46 was significantly upregulated in cervical cancer tissues compared to normal tissues, and its expression was associated with a poor prognosis. The findings suggest that CD46 could be a potential target for precision therapy in cervical cancer. [Extracted from the article]

A recent report from the First Affiliated Hospital of Hainan Medical College in Haikou, China, discusses the potential use of serum miR-182 as a biomarker for the diagnosis and prognosis of cervical cancer. The study involved 70 cervical cancer patients, 35 patients with cervical intraepithelial neoplasia, and 35 healthy controls. The researchers found that serum miR-182 expression was significantly different among the three groups and was associated with lymph node metastasis and pathological differentiation. The study concludes that serum miR-182 could be used as a biomarker for early diagnosis and as an independent factor influencing the survival and prognosis of cervical cancer patients. [Extracted from the article]

A new report from Tamil Nadu, India, discusses the importance of early detection and precise treatment for cervical cancer in women. The report introduces a new method called Heap Optimizer-based Self-Systematized Neural Fuzzy (HO-SsNF) for classifying cervical cancer cells using pap smear images. The proposed method achieves an impressive 99.6% accuracy in classification and has been integrated into cervical cancer diagnosis centers accessible through smartphone applications. The research provides valuable insights for advancing cancer prevention methods. [Extracted from the article]

A recent report from Islamic Azad University Science and Research Branch discusses the use of deep learning techniques for the diagnosis of cervical cancer. The researchers highlight the importance of early detection and the limitations of traditional clinical inspection methods. They explore the use of deep learning in improving the accuracy and efficiency of cervical cancer screening, specifically in cytology and colposcopy. The study reviews 24 selected papers and concludes that deep learning can enhance the precision and speed of cervical cancer analysis, potentially leading to early diagnosis and saving lives. [Extracted from the article]

A recent study conducted by researchers at the University of Saskatchewan in Saskatoon, Canada, explores the integration of local and global features for the classification of cervical cell images. The researchers designed a Deep Integrated Feature Fusion (DIFF) block to synergize these features from a convolutional neural network (CNN) branch and a transformer branch. The proposed method was evaluated on multiple datasets and demonstrated effectiveness in cervical cell classification, potentially aiding medical specialists in diagnosing cervical cancer. The research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the National Natural Science Foundation of China (NSFC). [Extracted from the article]

A recent study conducted by Mahidol University in Thailand has developed a new method for detecting high-risk HPV-16 genotypes in cervical cancers. The researchers created an electrochemical DNA biosensor integrated with an isothermal recombinase polymerase amplification (RPA) reaction, which exhibited high specificity and sensitivity. The biosensor had a limit of detection of 0.23 copies/muL of HPV-16 DNA and was validated through the analysis of 40 cervical tissue samples. The researchers believe that this electrochemical detection technology could be suitable for point-of-care testing in low-resource settings. [Extracted from the article]

A new study conducted by researchers at Umm Al-Qura University explores the use of artificial intelligence (AI) in improving the diagnosis of cervical cancer. The study focuses on a computer-aided diagnosis system that utilizes a deep learning algorithm to analyze Pap smear images and identify abnormalities associated with cervical cancer. The researchers developed a new algorithm called the Gazelle Optimization Algorithm with Deep Learning (CACCD-GOADL) model, which showed superior outcomes compared to other methods. This research has the potential to enhance early detection and accurate diagnosis of cervical cancer. [Extracted from the article]

A recent study conducted by researchers at the School of Medicine has focused on miRNA-based therapy for cervical cancer. Cervical cancer is a significant global health issue, with high rates of new cases and deaths. The study highlights the importance of epigenetic changes and miRNAs as biomarkers for early diagnosis, prognosis, and treatment response prediction in cervical cancer. The researchers aim to provide a summary of miRNA profiles at different stages of cervical cancer progression and their effects on target genes and signaling pathways. This research may contribute to the development of miRNA-based therapeutics and the use of miRNAs as biomarkers for cervical cancer prediction and diagnosis. [Extracted from the article]

A recent study conducted by researchers at Huazhong University of Science and Technology in Wuhan, China, proposes a new method for the classification of cervical precancerous lesions based on ConvNeXt. The traditional method of cervical cancer diagnosis relies on human papillomavirus (HPV) concentration testing, which can be costly and time-consuming. The researchers utilized self-supervised data augmentation and ensemble learning strategies to extract features and discriminate between different cell subtypes. The method was tested on a dataset of cervical cytology specimens and showed a higher classification accuracy compared to previous models. This research provides a promising approach for high-precision screening of cervical cancer. [Extracted from the article]

A study conducted at the Guangdong Women and Children Hospital explored the diagnostic and predictive potential of Septin9 DNA methylation in cervical cancer. The researchers found that methylated Septin9 was present in all cancerous tissues but not in cervicitis. The degree of Septin9 methylation increased with the severity of cervical lesions. When combined with HPV16/18 genotyping, Septin9 methylation showed increased sensitivity in detecting high-grade squamous intraepithelial lesion or cervical cancer. Additionally, plasma-based Septin9 methylation had a high specificity for predicting pelvic nodal metastasis of cervical cancer. The study aims to improve non-invasive predictive accuracy and reduce complications in cervical cancer diagnosis and treatment. [Extracted from the article]

A study conducted at Tianjin Fifth Central Hospital has found that a specific biomarker, circ_0000285, may be a promising diagnostic tool for early-stage cervical cancer. The researchers detected increased expression of circ_0000285 in serum and cervical exfoliated cells from preoperative cervical cancer patients compared to healthy volunteers. The biomarker was also found to be positively correlated with SCC-Ag level and HPV positive rate. The study suggests that circ_0000285 could be used as a non-invasive biomarker to improve the diagnosis of early-stage cervical cancer. [Extracted from the article]

• Propose a Bayesian Possibilistic C-Means clustering for missing attribute estimation. • The proposed BPCM can discover the underlying patterns in data. • Propose a fuzzy ensemble learning scheme for cervical cancer screening. Recently, a lot of attention has been given to the treatment of cervical cancer due to its high lethality and morbidity. Early screening of this disease is of vital importance. In this paper, we propose an automatic cervical cancer screening algorithm that analyzes the related risk factors to provide preliminary diagnostic information for medical practitioners. In cervical cancer screening, a number of risk factors are considered to be highly private or sensitive, and many patients elect not to provide the corresponding information. Such severe amount of missing attributes leads to great difficulties for many automatic screening algorithms. To solve this problem, a Bayesian Possibilistic C-means (BPCM in short) clustering algorithm is proposed to discover the representative patterns from the complete data and to estimate the missing values of a specific sample using its closest representative pattern. After the data completion step, a two-stage fuzzy ensemble learning scheme is proposed to derive the final screening result. In the first stage, the bootstrap aggregation (bagging in short) procedure is adopted to sample the entire class-imbalanced dataset into a number of class-balanced subsets. In the second stage, a number of weak classifiers are trained on each subset and a fuzzy logic based approach is designed to analyze the classification results of the weak classifiers and to obtain the final classification result. Experiments have been conducted on a dataset containing 858 patients. From the experiment results, it can be observed that the proposed BPCM can effectively discover the underlying patterns and is reliable in estimating the missing attribute compared with the traditional approaches. Moreover, by applying the proposed fuzzy ensemble learning scheme, the final classification results on the completed data by BPCM are promising (an accuracy of 76% or a positive sensitivity of 79%) under the severe missing-attribute scenario (only 6% samples with complete data). [ABSTRACT FROM AUTHOR]

Highlights • Models for cervical cancer screening are complex due to the multiplicity of HPV types • Microsimulation is typically used for model-based evaluation of screening strategies • We developed a deterministic model of screening outcomes, using compressed mixture representations • Our method was accurate and reduced dramatically the required computation times Abstract Cervical cancer arises differentially from infections with up to 14 high-risk human papillomavirus (HPV) types, making model-based evaluations of cervical cancer screening strategies computationally heavy and structurally complex. Thus, with the high number of HPV types, microsimulation is typically used to investigate cervical cancer screening strategies. We developed a feasible deterministic model that integrates varying natural history of cervical cancer by the different high-risk HPV types with compressed mixture representations of the screened population, allowing for fast computation of screening interventions. To evaluate the method, we built a corresponding microsimulation model. The outcomes of the deterministic model were stable over different levels of compression and agreed with the microsimulation model for all disease states, screening outcomes, and levels of cancer incidence. The compression reduced the computation time more than 1000 fold when compared to microsimulation in a cohort of 1 million women. The compressed mixture representations enable the assessment of uncertainties surrounding the natural history of cervical cancer and screening decisions in a computationally undemanding way. [ABSTRACT FROM AUTHOR]

A recent report from the University of Naples in Italy discusses the state of the art in the prevention, diagnosis, and treatment of cervical cancer. The study focuses on the role of surgery in different stages of the disease, including minimally invasive surgery and fertility-sparing surgery for young women. The research provides guidance for surgeons in managing patients, including those who desire to preserve fertility and those with tumors smaller than 4 cm. The report emphasizes the importance of vaccines and early diagnosis in combating cervical cancer globally. [Extracted from the article]

A patent has been issued for colposcopes, mammoscopes, and inserters with curved ends. These devices are used for cervical cancer screening and diagnosis. The patent describes an improved speculum design that aims to address issues of discomfort and pain during the procedure. The inventors have developed an inserter with a funnel-shaped distal end and a lip, along with an image capture device. The patent also mentions the current standard-of-care screening method in low and middle-income countries, which is visual inspection with acetic acid. The inventors highlight the need for improved speculum/colposcopic devices. The patent is assigned to Duke University. [Extracted from the article]

Researchers from Zhejiang Normal University in Jinhua, China have developed a label-free and highly accurate classification serum analytical platform for identifying cervical cancer at different stages. The platform utilizes a microarray chip to measure the surface-enhanced Raman scattering (SERS) spectra of serum from healthy subjects and cervical cancer patients. The researchers designed a binary weight robust principal component analysis (BWRPCA)-two-layer nearest neighbor (TLNN) model as a diagnosis and recognition tool for the SERS spectra. The model achieved an excellent classification accuracy of 91.2%, demonstrating the potential of SERS combined with BWRPCA-TLNN as a diagnostic screening method for improving cervical cancer detection and screening. [Extracted from the article]

A study conducted by researchers at Baylor College of Medicine in Texas has found geographic disparities in late-stage cervical cancer diagnosis in the United States. The study analyzed incident cervical cancer data from the Texas Cancer Registry from 2014 to 2018 and identified seven statistically significant clusters of late-stage cervical cancer diagnosis in Texas, with four being hot spots and three being cold spots. The hot spots were predominantly located in the South Texas Plains, Gulf Coast, and Prairies and Lakes regions. The study suggests that these communities may benefit from targeted interventions to address the disparities in cervical cancer diagnosis. [Extracted from the article]

A study conducted by researchers at Shandong University explores the role of N6-methyladenosine (m6A) methylation in cervical cancer. The study highlights the impact of m6A modification on cell proliferation, metastasis, metabolism, and therapeutic resistance within the tumor microenvironment. The researchers discuss the biogenesis of m6A, its regulators, molecular interactions, and functions in cervical cancer. They also summarize the clinical applications of m6A in the diagnosis and treatment of cervical cancer, and present new perspectives on detection methods, immune regulation, and nano-drug development. This study provides valuable insights for further research and potential clinical treatments for cervical cancer. [Extracted from the article]

A recent study conducted by researchers at the School of Electrical Engineering and Computer Science in Gwangju, South Korea, has developed a new deep learning network called MLNet for the diagnosis of cervical cancer. The MLNet model addresses common issues faced by existing models, such as over-fitting and parameter tuning problems. The researchers used particle swarm optimization and dynamically hybrid niching differential evolution to optimize the hyper-parameters of the convolutional neural network. The MLNet model outperformed existing models in terms of accuracy, f-measure, sensitivity, specificity, and precision on three benchmark cervical cancer datasets. This research has been peer-reviewed and published in the IEEE Journal of Biomedical and Health Informatics. [Extracted from the article]

A recent study conducted by researchers at National Taiwan Normal University explores a new approach to cervical cancer detection and segmentation using tissue images with multiple cells. The study utilizes a deep learning architecture based on Mask Region-Based Convolutional Neural Network (RCNN) and statistical analysis, achieving high detection rates and precise area segmentation. The proposed scheme generates a comprehensive report for medical consultants, aiding in the identification of malicious cells and expediting the diagnosis and treatment process. This research contributes to the field of oncology and women's health, providing valuable insights into cervical screening methods. [Extracted from the article]

For more information on this research see: Cervical Cancer Diagnosis Using Stacked Ensemble Model and Optimized Feature Selection: An Explainable Artificial Intelligence Approach. Keywords: Artificial Intelligence; Cancer; Cervical Cancer; Diagnostics and Screening; Emerging Technologies; Health and Medicine; Machine Learning; Oncology; Women's Health EN Artificial Intelligence Cancer Cervical Cancer Diagnostics and Screening Emerging Technologies Health and Medicine Machine Learning Oncology Women's Health 818 818 1 10/24/23 20231023 NES 231023 2023 OCT 24 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Fresh data on artificial intelligence are presented in a new report. [Extracted from the article]

Jammu Kashmir, India, Asia, Algorithms, Cancer, Cervical Cancer, Diagnostics and Screening, Health and Medicine, Oncology, Women's Health Keywords: Jammu Kashmir; India; Asia; Algorithms; Cancer; Cervical Cancer; Diagnostics and Screening; Health and Medicine; Oncology; Women's Health EN Jammu Kashmir India Asia Algorithms Cancer Cervical Cancer Diagnostics and Screening Health and Medicine Oncology Women's Health 1014 1014 1 10/03/23 20231006 NES 231006 2023 OCT 3 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A new study on Oncology - Cervical Cancer is now available. [Extracted from the article]

Keywords for this news article include: Oncology, Women's Health, Cervical Cancer, Health and Medicine, Ulsan National Institute of Science and Technology(UNIST). Under this agreement, UNIST will lead research and development efforts in cervical cancer diagnosis and treatment technologies, while EMCU will provide a clinical test bed for these advancements. Keywords: Cancer; Cervical Cancer; Health and Medicine; Oncology; Science And Technology; Ulsan National Institute of Science and Technology(UNIST); Women's Health EN Cancer Cervical Cancer Health and Medicine Oncology Science And Technology Ulsan National Institute of Science and Technology(UNIST) Women's Health 1106 1106 1 09/25/23 20230926 NES 230926 2023 SEP 26 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- UNIST has taken a significant step towards combating women's cancer on the African continent by signing an MOU with Eswatini Medical Christian University (EMCU) on. [Extracted from the article]

The focus of the article is to raise awareness about cervical cancer and promote education about its causes, screenings, and treatments. It recognizes January as Cervical Cancer Awareness Month, a national observance dedicated to spreading awareness about this disease. It highlights the statistics related to cervical cancer, including the estimated number of women diagnosed and the number of lives lost to cervical cancer in the U.S. in 2022.

The article provides several information regarding women's health and provides suggestions for maintaining the same. Topics discussed include need for regular medication and counseling for preventing anxiety; recommendation for undergoing cervical screening tests for diagnosis of the cervical cancer ; and information on hormone replacement therapy (HRT) which is medication containing female hormones to replace those the body no longer makes naturally after menopause.

Various cervical screening methods are available, but early screening with low-cost Pap smear tests is the key to curing. Pune, Pune, India, Asia, Cancer, Cancer Screening, Cervical Cancer, Cervical Screening, Diagnostics and Screening, Gynecology, Health and Medicine, Networks, Neural Networks, Oncology, Women's Health Keywords: Pune; India; Asia; Cancer; Cancer Screening; Cervical Cancer; Cervical Screening; Diagnostics and Screening; Gynecology; Health and Medicine; Networks; Neural Networks; Oncology; Women's Health EN Pune India Asia Cancer Cancer Screening Cervical Cancer Cervical Screening Diagnostics and Screening Gynecology Health and Medicine Networks Neural Networks Oncology Women's Health 974 974 1 08/21/23 20230822 NES 230822 2023 AUG 22 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Data detailed on Diagnostics and Screening - Cervical Screening have been presented. [Extracted from the article]

Keywords: Cancer; Cervical Cancer; Clinical Research; Clinical Trials and Studies; Diagnostics and Screening; Health and Medicine; Medical Records; Oncology; Oncology - Cervical Cancer; Pathology; Penn Medicine; Pharmaceutical Companies; Records as Topic; Women's Health EN Cancer Cervical Cancer Clinical Research Clinical Trials and Studies Diagnostics and Screening Health and Medicine Medical Records Oncology Oncology - Cervical Cancer Pathology Penn Medicine Pharmaceutical Companies Records as Topic Women's Health 1185 1185 1 07/31/23 20230801 NES 230801 2023 AUG 1 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Staff editors report on the newly launched clinical trial, NCT05952141, which has the following summary description: "Investigators will test the effectiveness of adaptive strategies on timely adoption of cervical cancer treatment in Botswana using a pragmatic trial design." The adaptive strategies are designed to target patient- and system-level determinants identified in preliminary data, including delayed communication of results, individual and structural barriers to accessing treatment, and suboptimal care coordination between referring and cancer treatment clinics. [Extracted from the article]

Study Data from University of Alabama Update Understanding of Type 2 Diabetes (Does the Intersectionality of Race/Ethnicity and Type 2 Diabetes Increase the Odds of a Cervical Cancer Diagnosis? According to news originating from Tuscaloosa, Alabama, by NewsRx correspondents, research stated, "Cervical cancer and Type 2 Diabetes (T2D) share common demographic risk factors. For more information on this research see: Does the Intersectionality of Race/Ethnicity and Type 2 Diabetes Increase the Odds of a Cervical Cancer Diagnosis?. [Extracted from the article]

To prove this hypothesis, in this paper, we focus on the complementary between overlapping cervical cell edge information and cell object information to get higher accuracy cell edge detection results. Keywords: Applied Sciences; Science EN Applied Sciences Science 809 809 1 07/17/23 20230718 NES 230718 2023 JUL 18 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Week -- Fresh data on applied sciences are presented in a new report. [Extracted from the article]

Overall, the AI system could be used as an assistive diagnostic tool for both proficient and inexperienced colposcopists in cervical cancer screenings to estimate the impression and location of pathologic lesions. Keywords: Artificial Intelligence; Cancer; Cervical Cancer; Clinical Research; Clinical Trials and Studies; Diagnostics and Screening; Emerging Technologies; Health and Medicine; Machine Learning; Oncology; Software; Women's Health EN Artificial Intelligence Cancer Cervical Cancer Clinical Research Clinical Trials and Studies Diagnostics and Screening Emerging Technologies Health and Medicine Machine Learning Oncology Software Women's Health 1299 1299 1 07/03/23 20230704 NES 230704 2023 JUL 4 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Fresh data on artificial intelligence are presented in a new report. [Extracted from the article]

Keywords: Cancer; Cervical Cancer; Diagnostics and Screening; Epidemiology; Health and Medicine; Oncology; Pediatrics; Women's Health EN Cancer Cervical Cancer Diagnostics and Screening Epidemiology Health and Medicine Oncology Pediatrics Women's Health 972 972 1 06/19/23 20230620 NES 230620 2023 JUN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Current study results on cervical cancer have been published. There is a need for more research on the social and economic impacts of cervical cancer in LMICs in order to provide evidence for expanded cervical cancer screening programs." According to the news editors, the research concluded: "We found that a cervical cancer diagnosis has not only on women, but their children as well, confirming that while largely preventable, cervical cancer has far-reaching impact beyond the woman diagnosed. [Extracted from the article]

Keywords for this news article include: State University of Campinas (UNICAMP), Ecology, Oncology, Women's Health, Cervical Cancer, Health and Medicine, Diagnostics and Screening. Keywords: Cancer; Cervical Cancer; Diagnostics and Screening; Ecology; Health and Medicine; Oncology; Women's Health EN Cancer Cervical Cancer Diagnostics and Screening Ecology Health and Medicine Oncology Women's Health 1120 1120 1 06/12/23 20230616 NES 230616 2023 JUN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators discuss new findings in cervical cancer. [Extracted from the article]

The article focuses on a study that highlights the role of health insurance coverage in mediating racial and ethnic inequities in advanced-stage cervical cancer diagnoses. The findings suggest that health insurance status is a modifiable risk factor that could reduce mortality inequities and improve survival rates among racial and ethnic minority groups.